COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey

by David Emes, Anke Hüls, Nicole Baumer, Mara Dierssen, Shiela Puri, Lauren Russell, Stephanie L. Sherman, Andre Strydom, Stefania Bargagna, Ana Cláudia Brandão, Alberto C. S. Costa, Patrick T. Feany, Brian Allen Chicoine, Sujay Ghosh, Anne-Sophie Rebillat, Giuseppina Sgandurra, Diletta Valentini, Tilman R. Rohrer, Johannes Levin, Monica Lakhanpaul, on behalf of the Trisomy 21 Research Society COVID-19 Initiative Study Group
Published 2021

Decreased body mass index in the preclinical stage of autosomal dominant Alzheimer’s disease

by Stephan Müller, Oliver Preische, Hamid R. Sohrabi, Susanne Gräber, Mathias Jucker, Janko Dietzsch, John M. Ringman, Ralph N. Martins, Eric McDade, Peter R. Schofield, Bernardino Ghetti, Martin Rossor, Neill R. Graff-Radford, Johannes Levin, Douglas Galasko, Kimberly A. Quaid, Stephen Salloway, Chengjie Xiong, Tammie Benzinger, Virginia Buckles, Colin L. Masters, Reisa Sperling, Randall J. Bateman, John C. Morris, Christoph Laske
Published 2017

Accelerated functional brain aging in pre-clinical familial Alzheimer’s disease

by Julie Gonneaud, Alex T. Baria, Alexa Pichet Binette, Brian A. Gordon, Jasmeer P. Chhatwal, Carlos Cruchaga, Mathias Jucker, Johannes Levin, Stephen Salloway, Martin Farlow, Serge Gauthier, Tammie L. S. Benzinger, John C. Morris, Randall J. Bateman, John C. S. Breitner, Judes Poirier, Etienne Vachon-Presseau, Sylvia Villeneuve, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Dominantly Inherited Alzheimer Network (DIAN) Study Group, Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer’s Disease (PREVENT-AD) Research Group
Published 2021